Korean J Dermatol.  2019 Jun;57(5):292-293.

Depigmentation in a Patient with Chronic Myeloid Leukemia during Chemotherapy with Dasatinib

Affiliations
  • 1Department of Dermatology, School of Medicine, Catholic University of Daegu, Daegu, Korea. magincia@cu.ac.kr

Abstract

No abstract available.

Keyword

Dasatinib; Hypopigmentation; Protein-tyrosine kinase

MeSH Terms

Dasatinib*
Drug Therapy*
Humans
Hypopigmentation
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Protein-Tyrosine Kinases
Dasatinib
Protein-Tyrosine Kinases
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr